Tretinoin Cream

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-23-R-0005

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Logistics Agency (DLA Troop Support) has announced a presolicitation for a forthcoming national requirements contract for Tretinoin Cream, under procurement identifier SPE2D2-23-R-0005. This initiative aims to establish a reliable, nationwide supply source for Tretinoin Cream in three concentrations—0.025%, 0.05%, and 0.1%—packaged in both 20-gram and 45-gram tubes. The contract will serve the needs of multiple federal entities, including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, with distribution facilitated through the DLA and VA prime vendor programs. The scope of this procurement encompasses the provision of commercial pharmaceutical products, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505. The acquisition will be conducted as an unrestricted, fully competitive process, inviting proposals from all qualified sources. The contract structure is firm-fixed price and requirements-based, featuring a one-year base period with four additional one-year option periods, ensuring continuity and flexibility in meeting annual demand. Specific annual usage estimates will be detailed in the Schedule of Supplies section of the solicitation. This opportunity will be solicited in accordance with FAR Part 12, governing commercial item acquisitions, and FAR 52.216-21 (Requirements), which outlines the framework for requirements contracts. There are no set-aside restrictions, making this solicitation accessible to all capable suppliers. The intended outcome is to secure a dependable supply chain for Tretinoin Cream, supporting the healthcare needs of federal agencies and their beneficiaries. Interested contractors are encouraged to monitor the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and www.SAM.gov for the official release of the solicitation and any subsequent updates. Automated notifications for changes to the presolicitation or solicitation can be set up through these platforms. The projected solicitation date is February 2023, though DLA reserves the right to adjust this timeline as necessary. For further information or to submit questions, contractors may contact the primary point of contact, Ryan Ferry, at [email protected] or 215-737-3182. A secondary contact, Jason Wray, is also available at [email protected] or 215-737-0614. The notice remains active and can be accessed via SAM.gov at https://sam.gov/opp/3da93e9a7ce4497f93f0bbef952d0188/view. This presolicitation represents a significant opportunity for manufacturers and suppliers of pharmaceutical preparations to support federal healthcare programs through a stable, long-term contract. Contractors should review the requirements carefully and assess their capacity to meet the outlined specifications and delivery expectations over the contract lifecycle.